Cytokinetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.

About CYTK

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. 

CEO
Robert I. Blum
CEORobert I. Blum
Employees
423
Employees423
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
1997
Founded1997
Employees
423
Employees423

CYTK Key Statistics

Market cap
6.19B
Market cap6.19B
Price-Earnings ratio
-9.98
Price-Earnings ratio-9.98
Dividend yield
Dividend yield
Average volume
2.28M
Average volume2.28M
High today
$54.35
High today$54.35
Low today
$51.87
Low today$51.87
Open price
$52.23
Open price$52.23
Volume
1.18M
Volume1.18M
52 Week high
$110.25
52 Week high$110.25
52 Week low
$25.98
52 Week low$25.98

CYTK News

Yahoo Finance 5d
Insider Sale at Cytokinetics Inc by EVP of Research & Development - Yahoo Finance

Fady Malik, Executive Vice President of Research & Development at Cytokinetics Inc (NASDAQ:CYTK), sold 7,788 shares of the company on June 11, 2024. The transac...

Insider Sale at Cytokinetics Inc by EVP of Research & Development - Yahoo Finance

Analyst ratings

83%

of 18 ratings
Buy
83.3%
Hold
16.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.